Deal Library / Pharma BD Deal Intelligence

Allergan plc — Pharma Deals

The Pharma Closeout tracks 14 deals, $13.6B in disclosed deal value, 14 with a post-close Outcome Score for Allergan plc.

Median Critic Score: 77 · Median Outcome Score: 18

All 14 deals

Allergan plc / Merck & Co., Inc. (CGRP receptor antagonist program) — 2015 · $250M · Worked — the deal delivered on its rationale.
Allergan plc / SkinMedica, Inc. — 2012 · $375M · Mixed — partial payoff, real shortfalls.
Allergan plc / Inamed Corporation — 2005 · $3.2B · Mixed — partial payoff, real shortfalls.
Allergan plc / Oculeve, Inc. — 2015 · $250M · Underwhelmed — fell short of the thesis.
Allergan plc / Zeltiq Aesthetics, Inc. — 2017 · $2.5B · Underwhelmed — fell short of the thesis.
Allergan plc / Kythera Biopharmaceuticals, Inc. — 2015 · $2.1B · Did not work — the deal failed to deliver.
Allergan plc / Anterios, Inc. — 2016 · $90M · Did not work — the deal failed to deliver.
Allergan plc / MAP Pharmaceuticals Inc. — 2013 · $958M · Did not work — the deal failed to deliver.
Allergan plc / Topokine Therapeutics, Inc. — 2016 · $85M · Did not work — the deal failed to deliver.
Allergan plc / Tobira Therapeutics, Inc. — 2016 · $1.7B · Did not work — the deal failed to deliver.
Allergan plc / ForSight VISION5, Inc. — 2016 · $95M · Did not work — the deal failed to deliver.
Allergan plc / Naurex, Inc. — 2015 · $560M · Did not work — the deal failed to deliver.
Allergan plc / Vitae Pharmaceuticals, Inc. — 2016 · $639M · Did not work — the deal failed to deliver.
Allergan plc / Heptares Therapeutics Ltd. — 2016 · $790M · Did not work — the deal failed to deliver.